Reflecting the company’s shift towards specialty ingredients, the investment in its Biopolis plant will also give wider analytical capabilities, including updated technology to predict shelf life for products, which will help reduce product development time.
Tate & Lyle this year recorded a five percent rise in global profits, after a fluctuating few years of trading.
The lab expansion is due for completion by the end of the first quarter of 2017.
The company is also shifting away from sucralose, due to falling global profit margins. It previously closed its Singapore sucralose site in 2015.